-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
MiNK Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- MiNK Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.88M, a 63.9% increase year-over-year.
- MiNK Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$14.3M, a 43.6% increase year-over-year.
- MiNK Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$22.9M, a 25.9% increase from 2022.
- MiNK Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$30.9M, a 9.14% decline from 2021.
- MiNK Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$28.4M, a 93.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)